Læknablaðið

Årgang

Læknablaðið - 01.04.1978, Side 68

Læknablaðið - 01.04.1978, Side 68
82 LÆKNABLAÐIÐ 72. Pell, S. & D'Alonzo, C.A. Acute myocardial infarction in a larpe industrial population. — Report of 6-year study of 1356 cases. JAMA 105, 831. 1963. 73. Peters, T.J. & de Deuve. Lysomes of t.he arterial wall. J. Exp. Med. 136: 117, 1972. 74. Pikkarainen, J. et al.: Serum cholesterol in Finnish twins. Amer. J. Hum. Genet. 18, 115. 1966. 75. Pyke, D.A. Arterial disease and diabetes í Clinical Diabetes (Oakley, W.E., Pyke, D.A. & Taylor, K.W.) [Blackwell Sci. Publ.] Ox- ford. 1968. 76. Rannsóknarstöð Hjartaverndar. Skýrsla AIII. Betalipoprotein, tótal kólesteról op brífflyser- íðar í venublóði ísl. karla á aldrinum 34—61 árs. 77. Recommendation from the findings by the RCGP oral contraception study on the morta- lity risks of oral cont.receptive users. Brit. Med. J. 2, 947. 1977. 78. Reid, D.D. et al.: Smokinp: and other risk factors for coronary heart-disease in British civil servants. Lancet 979-984. 1976. 79. Robertson, W.B. The International Atheros- clerosis Project, Path. Microbiol. 30:810. 1967. 80. Rose, G. Detection of hiph coronary risk. Postgrad. Med. J. 52, 452. 1976. 81. Rose, G. Smoking and cardiovascular disease. Amer. Heart J. 85, 838-840. 1973. 82. Rose, G. Familial pattern in ischaemic heart disease. Brit. J. prev. soc. Med. 18, 75. 1964. 83. Rose, G. et al.: Myocardial ischaemia, risk factors and deat.h from coronary heart dis- ease. Lancet 105. 1977. 84. Rosenman, R.H. et al.: Multivariate prediction of coronary heart disease during 8.5 year follow up in the Western Collaborative Group Study. Amer. J. Cardiol. 37:903. 1976. 85. Ross, R. & Glomset, J.A. The pathogenesis of atherosclerosis. New Engl. J. Med. 295:369- 377, 420-425. 1976. 86. Ross, R. & Harker, L. Hyperlipidemia and atherosclerosis; Chronic hyperlipemia iniates and maintains lesions by endot.helial cell des- quamation and lipid accumulation. Science 193:1094-1100. 1976. 87 Royal College of General Practitioners* Oral Contraception Study. Mortality among oral- contraceptive users. Lancet 727. 1977. 88. Schievelbein. H. & Eberhardt, R.J. natn. Cancer Inst. 48, 1785. 1972. 89. Schaefer, L.E. et al.: Heredity, environment and serum cholesterol. Circulation 17, 537. 1958. 90. Shaper, A.G. Primary aiyi secondary pre- vention trials in coronary heart disease. Post- grad. Med. J. 52. 464. 1976. 91. Sigurðsson G. et al.: Conversion of very low density lipoprotein to low density lipoprotein. J. Clin. Invest 56. 1481. 1975. 92. Sigurðsson, G. et al.: Quantification of the hepatic cont.ribution to the catabolism of high density aDolipoprotein in the rat. Circulation (Suppl. III), 3, 1977. 93. Sigurjónsson, J. Occupational variations in mortality from ischaemic heart. disease. J. Am. Geriatr. Soc. 19, 34. 1971. 94. Siperstein, M.D. The glucose tolerance test: nitfall in t.he diagnosis of diabetes mellitus. T Controversy in Medicine II. (Ingelfinger, F.J. cd.) TSaundersl 1972. 95. Slack, J. Genetic differences in liability to ntherosclerotic heart disease. J. Roy. Coll. Phycns. London. 8. 115. 1974. 96. Slack, J. & Evans, K.A. The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women wit.h ischaemic heart disease. J. Med. Genet. 3, 239. 1966. 97. Smith. E.B. The Relationship Between Plasma and Tissue Lipids in Human Atherosclerosis. Adv. Lipid Res. 12, 49. 1974. 98. Smith, E.B. & Slater, R.S. Relationship between low-densit.y lipoprotein in aortic in- tima and serum-lipid levels. Lancet, i, 463. 1972. 99. Smith, E.B. & Smith, R.H. Early Changes in Aortic Intima. Atherosclerosis Reviews, Vol. I, p.p. 119-134. (Ed. R. Paoletti & A.M. Gotts) [Raven Press] N.Y. 1976. 100. Stamler, J. Bull. N.Y. Acad. Med. 44, 1476. 1968. 101. Stamler, J. et al.: Risk factors: Their role in the etiology and pathogenesis of the athero- sclerotic diseases. Pathogenesis of athero sclerosis (eds. Wissler, R.W. & Geer, J.C.) [Williams & Wilkins] Baltimore, Maryland. 1972. 102. Stern, M.P. et al.: Cardiovascular risk and use of estrogens or estrogenprogestagen combi- nation. JAMA 235, 811. 1976. 103. Stokes, T. & Wynn, V. serum lipids in women on oral contraceptives. Lancet 677. 1971. 104. Taylor, H.L. Occupational factors in the study of coronary heart disease and physical acti- vit.y. Canad. Med. Ass. J. 96, 825. 1967. 105. Taylor, H.L. et al.: Five year follow-up of employees of selected U.S. railroad companies. í Coronary Heart. Disease in Seven Countries. (Keyes A. Ed.) Circulation. Apríl 1970. 106. Ten-year follow-up report on Birmingham Diabetes Survey of 1961. Brit. Med. J. 2, 35. 1976. 107. Trial of Clofibrate in the treatment of ischa- emic heart. disease. Five year study by a group of physicians of the Newcastle upon Tyne Region. Brit. Med. J. 4, 767. 1971. 108. The University Group Diabetes Program: A study of the effect of hypoglycemic agents on vascular complications in patients with adult onset diabetes. Part II: Mortality results. Diabetes 19 (Suppl. 2) 747-830. 1970. Part V: Evaluation of Phenformin t.herapy. Diabetes 24 (Suppl 1) :65-184. 1975. 109: Vesselinovitch, D. et al.: Reversal of advanced atherosclerosis in rhesus monkeys. Part 1: Light microscopic studies. Atherosclerosis, 23: 155. 1976. 110. Vessey, M.P. et al.: Mortality among women participat.ing in the Oxford family planning association contraceptive study. Lancet 731. 1977. 111. Veterans Administration Cooperative Study; Effects of t.reatment on morbidity in hyper- tension. JAMA 202, 116-122. 1967. 112. Veterans Administration Cooperative Study; Effects of treatment on morbidity in hyper- t^nsion II. JAMA 213, 1143-1152. 1970. 113. Walker, W.J. Changing United States Life- Style: and declining vascular mortality; cause or coincidense. New Engl. J. Med. 297, 163. 1977. 114. Walton, K.W. Identification of Lipoproteins involved in Human Atherosclerosis. Athero- sclerosis III (ed. G. Schet.tler & A. Weigel) [Springer] Berlin. 1974. 115. Wilhelmsson, C. et al.: Smoking and myo- cardial infarction. Lancet i, 415. 1975. 116. Zilversmit, D.B. Role of triglyceride — rich lipoproteins in atherogenesis. Ann. N.Y. Acad. Sci. 275, 138. 1976.
Side 1
Side 2
Side 3
Side 4
Side 5
Side 6
Side 7
Side 8
Side 9
Side 10
Side 11
Side 12
Side 13
Side 14
Side 15
Side 16
Side 17
Side 18
Side 19
Side 20
Side 21
Side 22
Side 23
Side 24
Side 25
Side 26
Side 27
Side 28
Side 29
Side 30
Side 31
Side 32
Side 33
Side 34
Side 35
Side 36
Side 37
Side 38
Side 39
Side 40
Side 41
Side 42
Side 43
Side 44
Side 45
Side 46
Side 47
Side 48
Side 49
Side 50
Side 51
Side 52
Side 53
Side 54
Side 55
Side 56
Side 57
Side 58
Side 59
Side 60
Side 61
Side 62
Side 63
Side 64
Side 65
Side 66
Side 67
Side 68
Side 69
Side 70
Side 71
Side 72
Side 73
Side 74
Side 75
Side 76
Side 77
Side 78
Side 79
Side 80
Side 81
Side 82
Side 83
Side 84
Side 85
Side 86
Side 87
Side 88
Side 89
Side 90
Side 91
Side 92
Side 93
Side 94
Side 95
Side 96
Side 97
Side 98
Side 99
Side 100
Side 101
Side 102
Side 103
Side 104
Side 105
Side 106
Side 107
Side 108
Side 109
Side 110

x

Læknablaðið

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.